DKSH radiates compassion by extending support to a cancer hospital in India

DKSH India has donated to Tata Memorial Hospital in Mumbai to assist in procuring over 450  central line access catheters (4fr Groshong) PICC kits, enhancing cancer patient care for those in  need

DKSH, a leading distributor of specialty chemicals and ingredients,  extended its support to Tata Memorial Hospital in Mumbai with a donation. DKSH’s contribution to Tata  Memorial Hospital allows it to procure central line access catheters and therefore serves as a tangible  beacon of hope for cancer patients seeking treatment, representing a source of encouragement amidst  their challenging journeys. 

This donation is in line with DKSH’s sustainability initiatives, through which the company creates  opportunities for development and improvement across society. DKSH is deeply rooted in the  communities it serves and strives to create positive impacts beyond business activities. A strong  commitment to the local communities that the company is active in has always been an integral part of  its business.  

Tata Memorial Hospital conducts over 150,000 chemotherapy sessions annually in its outpatient ward.  However, patients in need of continuous or prolonged chemotherapy cannot receive it in this setting.  Instead, they undergo central venous line access, involving the insertion of a catheter into their central  venous system, typically the superior vena cava, through which chemotherapy is administered. This  allows patients to return home while receiving ongoing chemotherapy, reducing hospital stays and the  risk of complications such as leakage or infection. The standard catheter used for this purpose is the 4fr  Groshong, the one Tata Memorial Hospital can procure with DKSH’s donation. On average, around 250  patients require this catheter every month. 

Dr C S Pramesh, Director, Tata Memorial Hospital, commented, “On behalf of our patients, we are deeply  grateful to DKSH for their generous support in providing central line venous access catheters. This  contribution will greatly enhance access to chemotherapy, offering greater convenience and comfort to  our patients.” 

Vishal Jawale, Managing Director, DKSH India, stated, “We are very pleased to serve this noble cause.  This project aimed at enhancing lives aligns perfectly with our overall sustainability strategy and our  specific objective of creating a positive local impact in the communities we serve.” 

DKSH, a leading distributor of specialty chemicals and ingredients,  extended its support to Tata Memorial Hospital in Mumbai with a donation. DKSH’s contribution to Tata  Memorial Hospital allows it to procure central line access catheters and therefore serves as a tangible  beacon of hope for cancer patients seeking treatment, representing a source of encouragement amidst  their challenging journeys. 

This donation is in line with DKSH’s sustainability initiatives, through which the company creates  opportunities for development and improvement across society. DKSH is deeply rooted in the  communities it serves and strives to create positive impacts beyond business activities. A strong  commitment to the local communities that the company is active in has always been an integral part of  its business.  

Tata Memorial Hospital conducts over 150,000 chemotherapy sessions annually in its outpatient ward.  However, patients in need of continuous or prolonged chemotherapy cannot receive it in this setting.  Instead, they undergo central venous line access, involving the insertion of a catheter into their central  venous system, typically the superior vena cava, through which chemotherapy is administered. This  allows patients to return home while receiving ongoing chemotherapy, reducing hospital stays and the  risk of complications such as leakage or infection. The standard catheter used for this purpose is the 4fr  Groshong, the one Tata Memorial Hospital can procure with DKSH’s donation. On average, around 250  patients require this catheter every month. 

Dr C S Pramesh, Director, Tata Memorial Hospital, commented, “On behalf of our patients, we are deeply  grateful to DKSH for their generous support in providing central line venous access catheters. This  contribution will greatly enhance access to chemotherapy, offering greater convenience and comfort to  our patients.” 

Vishal Jawale, Managing Director, DKSH India, stated, “We are very pleased to serve this noble cause.  This project aimed at enhancing lives aligns perfectly with our overall sustainability strategy and our  specific objective of creating a positive local impact in the communities we serve.”